My Macmillan

Publications directory

Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm

The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.

Results: 37

Cover image of 'Know your body. Spot cancer early. Skin cancer'

Know your body. Spot cancer early. Skin cancer (February 2018)

Cancer Research UK

This leaflet describes the early signs of skin cancer and includes photographs to help spot the signs.

Cover image of 'Pembrolizumab (Keytruda®) [Chinese, Traditional]'

Pembrolizumab (Keytruda®) [Chinese, Traditional] (May 2018)

Macmillan Cancer Support

Pembrolizumab (Keytruda®) is used to treat melanoma that has spread or cannot be removed (advanced melanoma). It is also used for non-small cell lung cancer, Hodgkin lymphoma, and bladder cancer. This factsheet describes how it works, how it is given, and the possible side-effects.

Cover image of 'P.S. I have cancer. Wrestling melanoma and falling in love'

P.S. I have cancer. Wrestling melanoma and falling in love (2018)

Poetry Space Ltd

Mark Sims, a young doctor was diagnosed with advanced skin cancer just before his 27th birthday. This is the story of his 23-month wrestle with the disease, his passion to raise awareness and funds for vital research and how he found love quite unexpectedly, while working through his bucket list. Sadly, Mark died on January 19th 2017. His book is being published posthumously. (Publisher)

Cover image of 'The neuroscientist who lost her mind. A memoir of madness and recovery'

The neuroscientist who lost her mind. A memoir of madness and recovery (2018)

Bantam Press (imprint of Transworld Publications)

All we think, feel and dream, how we move, if we move, everything that makes us who we are, comes from the brain. We are the brain. So what happens when the brain fails? What happens when we lose our mind? In January 2015, renowned neuroscientist Barbara Lipska's melanoma spread to her brain. It was, in effect, a death sentence. She had surgery, radiation treatments and entered an immunotherapy clinical trial. And then her brain started to play tricks on her. The expert on mental illness - who had spent a career trying to work out how the brain operates and what happens when it fails - experienced what it is like to go mad. She began to exhibit paranoia and schizophrenia-like symptoms. She became disinhibited, completely unaware of her inappropriate behaviour. She got lost driving home from work, a journey she did every day. She couldn't remember things that had just happened to her. Small details like what she was having for breakfast became an obsession, but she ignored the fact that she was about to die. And she remembers every moment with absolute clarity. Weaving the science of the mind and the biology of the brain into her deeply personal story, this is the dramatic account of Dr Lipska's own brilliant brain gone awry. (Publisher)

Cover image of 'Interferon alpha [Arabic]'

Interferon alpha [Arabic] (March 2017)

Macmillan Cancer Support

Interferon alpha is a biological therapy that may be used to treat kidney cancer, melanoma, carcinoid tumours, and some types of lymphoma and leukaemia. This factsheet describes how it works, how it is given, and some of the possible side-effects. Includes the English-language version.

Cover image of 'Ipilimumab [Bulgarian]'

Ipilimumab [Bulgarian] (March 2017)

Macmillan Cancer Support

Ipilimumab is a targeted therapy drug used to treat advanced melanoma. This describes how it works, how it is given, and some of the possible side-effects.

Cover image of 'Interferon alpha (IntronA®, Roferon-A®) [French]'

Interferon alpha (IntronA®, Roferon-A®) [French] (February 2017)

Macmillan Cancer Support

Interferon alpha is a biological therapy that may be used to treat kidney cancer, melanoma, carcinoid tumours, and some types of lymphoma and leukaemia. This factsheet describes how it works, how it is given, and some of the possible side-effects.

Cover image of 'The essential guide to skin cancer'

The essential guide to skin cancer (2017)

Need2Know

Each year we are all warned about the dangers of UVA rays and how important it is to protect ourselves from the damaging effects they have on our skin. Up to 90% of skin cancer could be prevented if we were more aware of sun safety issues. This guide aims to provide expert advice and the latest research on sun safety and the treatment of skin cancer. There are chapters on how to use sunscreen, how a diagnosis of skin cancer is made and ways the skin can be treated during and after cancer. Subjects included are the different types of skin cancer, risk factors, the emotional effects of skin cancer and aftercare, plus up-to-date, straightforward information on sunscreen, sun beds and treatments. There are also lots of practical tips for staying safe in the sun. Whether you have just been diagnosed as having sun damaged skin or want advice on protecting yourself and your family in the sun, this guide provides the essential information. (Publisher)

Cover image of 'Nivolumab (OPDIVO®)  [Polish]'

Nivolumab (OPDIVO®) [Polish] (2016)

Macmillan Cancer Support

Nivolumab (OPDIVO®) is a targeted therapy drug used to treat melanoma, non-small cell lung cancer or kidney (renal cell) cancer. 

Cover image of 'Nivolumab (OPDIVO®)  [Bulgarian]'

Nivolumab (OPDIVO®) [Bulgarian] (2016)

Macmillan Cancer Support

Nivolumab (OPDIVO®) is a targeted therapy drug used to treat melanoma, non-small cell lung cancer or kidney (renal cell) cancer. 

Sorry, no publications found.
Need to talk? Call us free*
0800 808 00 00 Monday to Friday, 9am-8pm